Study to Evaluate Oral Mucosa Absorption of IN-C004 in Healthy Volunteers

HK inno.N

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Drug: IN-C004

Study type: Interventional

Funder types: Industry

Identifiers

NCT04654065

IN_KOD_101

Details and patient eligibility

About

To evaluate whether IN-C004 absorbs oral mucosa in healthy volunteers.

Full description

An Open-label, Single-dose Clinical Study

Enrollment: 6 patients

Sex: All

Ages: 19 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Body mass index (BMI) ≥19.0 kg/m2 and ≤27.0 kg/m2 with a body weight ≥ 45 kg at screening.

Exclusion criteria

• History or evidence of clinically significant disease
• History of drug/alcohol abuse
• Participated in other studies and received investigational products within 6 months prior to the first study dose.
• Not able to use a medically acceptable contraceptive method throughout the study.

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

6 participants in 1 patient group

IN-C004

Experimental group

Description:

IN-C004

Treatment:

Drug: IN-C004